Juan Guanira
Overview
Explore the profile of Juan Guanira including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
1103
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Silva M, Torres T, Coutinho C, Moreira R, da Costa Leite I, Cunha M, et al.
Lancet HIV
. 2024 Sep;
11(10):e670-e679.
PMID: 39243787
Background: The global burden of sexually transmitted infections (STIs) poses a challenge in the context of HIV pre-exposure prophylaxis (PrEP) programmes. We aimed to explore factors associated with prevalent, incident,...
2.
Janes H, Brown M, Glidden D, Mayer K, Buchbinder S, McMahan V, et al.
PLoS One
. 2019 Sep;
14(9):e0222183.
PMID: 31536518
Introduction: Developing guidelines to inform the use of antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention in resource-limited settings must necessarily be informed by considering the resources and infrastructure needed for...
3.
Llanos R, Ramirez Ramirez R, Palacios M, Flores C, Borda-Olivas A, Castillo R, et al.
Rev Saude Publica
. 2019 Apr;
53:33.
PMID: 30942275
Objective: To report the design, methodology and initial results of the National Socioeconomic Survey of Access to Health of the EsSalud Insured. Results: There were interviews in 25,000 homes, surveying...
4.
Glidden D, Mulligan K, McMahan V, Anderson P, Guanira J, Chariyalertsak S, et al.
Clin Infect Dis
. 2018 Feb;
67(3):411-419.
PMID: 29415175
Background: Antiretroviral drugs have been associated with changes in lipids, fat mass and dat distribution. Tenofovir disoproxil fumarate (TDF) has been shown to have a more favorable metabolic profile than...
5.
Glidden D, Mulligan K, McMahan V, Anderson P, Guanira J, Chariyalertsak S, et al.
J Acquir Immune Defic Syndr
. 2017 Jun;
76(2):177-182.
PMID: 28639995
Background: Oral tenofovir disoproxil fumarate (TDF) for HIV prevention and treatment is associated with decreases in bone mineral density (BMD). Previous reports suggest that these changes may be reversible after...
6.
Gandhi M, Glidden D, Mayer K, Schechter M, Buchbinder S, Grinsztejn B, et al.
Lancet HIV
. 2016 Sep;
3(11):e521-e528.
PMID: 27658870
Background: As pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine for the prevention of HIV infection is rolled out internationally, strategies to maintain effectiveness and to minimise adverse effects...
7.
Amico K, Mehrotra M, Avelino-Silva V, McMahan V, Veloso V, Anderson P, et al.
AIDS Behav
. 2016 Mar;
20(7):1535-40.
PMID: 26992393
Monitoring adherence to pre-exposure prophylaxis (PrEP) is part of the recommended package for PrEP prescribing, yet ongoing concerns about how to do so confidently are exacerbated by gross discrepancies in...
8.
Glidden D, Amico K, Liu A, Hosek S, Anderson P, Buchbinder S, et al.
Clin Infect Dis
. 2016 Jan;
62(9):1172-7.
PMID: 26797207
Background: Blinded clinical trials have reported a modest and transient "start-up syndrome" with initiation of tenofovir-based pre-exposure prophylaxis (PrEP). We evaluate this phenomenon and its effect on adherence in an...
9.
Deutsch M, Glidden D, Sevelius J, Keatley J, McMahan V, Guanira J, et al.
Lancet HIV
. 2015 Nov;
2(12):e512-9.
PMID: 26614965
Background: Pre-exposure prophylaxis (PrEP) with oral emtricitabine and tenofovir disoproxil fumarate is used to prevent the sexual acquisition of HIV in groups at high risk such as transgender women. We...
10.
Grant R, Anderson P, McMahan V, Liu A, Amico K, Mehrotra M, et al.
Lancet Infect Dis
. 2014 Jul;
14(9):820-9.
PMID: 25065857
Background: The effect of HIV pre-exposure prophylaxis (PrEP) depends on uptake, adherence, and sexual practices. We aimed to assess these factors in a cohort of HIV-negative people at risk of...